May 6
Hype Or Hope? Latest Research On GLP-1 Receptor Agonists And Addiction
Glucagon-like peptide (GLP-1) receptor agonists like semaglutide and liraglutide are already game-changers for obesity and type 2 diabetes. Could addiction be next?
I was stunned when my ADHD symptoms vanished – along with 3st – as soon as I started taking weight loss jabs
TOPPING the scales at 16 stone, Joann Burland knew something had to change. At 5ft 2in and a size 20, the 49-year-old from Basildon, Essex, was tired of hiding in baggy clothes and exhausted from years of failed diets. John McLellanJoann now feels better both mentally and physically[/caption] SuppliedJoann, pictured with son Luke and husband … Read more
In adults with overweight or obesity and without diabetes, GLP-1 RAs increase weight loss vs. placebo
Annals of Internal Medicine, Ahead of Print.
Illumina, Ovation Release GLP-1 Patient Dataset
<div><p paraid=”1052830088″ paraeid=”{1c084551-346b-4cb6-8208-64c606d219f8}{9}”><b>By Bio-IT World Staff </b></p></div><div><p paraid=”535832799″ paraeid=”{1c084551-346b-4cb6-8208-64c606d219f8}{15}”><b>May 6, 2025</b> | Last week Illumina and Ovation.io announced the development of the largest commercially-available clinical multiomic dataset from 25,000 patients treated with glucagon-like peptide-1 (GLP-1) receptor agonist therapies. The dataset will be made available to the pharma community to advance drug discovery and development. This collaboration … Read more
Wegovy Reduced Inflammation, Scarring in People with Serious Liver Disease
Wegovy resolved liver inflammation in nearly two-thirds of participants in a major clinical trial, twice the rate seen with placebo. Steve Christo-Corbis/Getty Images Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate … Read more
Interest in weight-loss jabs is surging – here’s what semaglutide does to your body
Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by Harley Street Skin Clinic found semaglutide – sold under the brand names Wegovy for weight loss and Ozempic for diabetes – is the most searched weight-loss medication, with over 16 million Google searches last … Read more
The Ozempic pill is on the way, but one big US company won’t be making it
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It’s also likely to be cheaper and not suffer the same kind of supply-chain shortages that existing therapeutics have faced. But it’s been a dramatic few weeks for the leading three drug-makers vying to usher in this … Read more